| DOMESTIC-DIRECT-END-USERS-CUSTOMERS |
DOMESTIC-DIRECT-END-USERS-CUSTOMERS |
90%
|
For the fiscal years ended December 31, 2025, 2024, and 2023, our sales of disposable medical devices to domestic direct end users customers and domestic distributor customers accounted for 97.34%, 9… |
| DOMESTIC-DISTRIBUTOR-CUSTOMERS |
DOMESTIC-DISTRIBUTOR-CUSTOMERS |
90%
|
For the fiscal years ended December 31, 2025, 2024, and 2023, our sales of disposable medical devices to domestic direct end users customers and domestic distributor customers accounted for 97.34%, 9… |
| JIANGSU-YADA-TECHNOLOGY-GROUP-CO-LTD |
JIANGSU-YADA-TECHNOLOGY-GROUP-CO-LTD |
85%
|
uses on the manufacturing, sales and distributions of non-bottled products, such as brushes, ID bracelets for domestic sales. ● Jiangsu Yada Technology Group Co., Ltd., or Jiangsu Yada: a subsidiary … |
| OVERSEAS-DISTRIBUTING-CUSTOMERS |
OVERSEAS-DISTRIBUTING-CUSTOMERS |
80%
|
For the fiscal years ended December 31, 2025, 2024, and 2023, our sales of disposable medical devices to overseas distributing customers accounted for 0.04%, 0.04%, and 0.50%, respectively, of our re… |
| BRIGHT-ACCOMPLISH-LIMITED |
BRIGHT-ACCOMPLISH-LIMITED |
62%
|
and 186,000 shares (or 31%) from Yin Liu, respectively, resulting in Kang Fu International Medical becoming Meihua’s wholly owned subsidiary. In exchange for the acquisition on Kang Fu, Meihua issued… |
| CO-LTD |
CO-LTD |
62%
|
vice Co., Ltd., and Yangzhou Jiangzhou Medical Device Co., Ltd., representing 12.14%, 9.93% and 8.67% of our total purchase respectively. For the year ended December 31, 2024, our three most signific… |
| HAINAN-RUIYING-TECHNOLOGY-CO-LTD |
HAINAN-RUIYING-TECHNOLOGY-CO-LTD |
62%
|
uses on the manufacturing, sales and distributions of non-bottled products, such as brushes, ID bracelets for domestic sales. ● Jiangsu Yada Technology Group Co., Ltd., or Jiangsu Yada: a subsidiary … |
| JIANGSU-HUADONG-MEDICAL-DEVICE-INDUSTRIAL-CO-LTD |
JIANGSU-HUADONG-MEDICAL-DEVICE-INDUSTRIAL-CO-LTD |
62%
|
uses on the manufacturing, sales and distributions of non-bottled products, such as brushes, ID bracelets for domestic sales. ● Jiangsu Yada Technology Group Co., Ltd., or Jiangsu Yada: a subsidiary … |
| KANG-FU-INTERNATIONAL-MEDICAL-CO-LIMITED |
KANG-FU-INTERNATIONAL-MEDICAL-CO-LIMITED |
62%
|
Form 20-F/A filed on August 29, 2023) 2.3 Share Exchange Agreement by and among Meihua International Medical Technologies Co., Ltd., Kang Fu International Medical Co., Limited, and shareholders of Ka… |
| LI-CPA-LLC |
LI-CPA-LLC |
62%
|
lt or impossible. 23 We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability… |
| LTD-YANGZHOU-XIAGUANG-MEDICAL-DEVICE-CO-LTD |
LTD-YANGZHOU-XIAGUANG-MEDICAL-DEVICE-CO-LTD |
62%
|
, Ltd., Yangzhou Xiaguang Medical Device Co., Ltd., and Yangzhou Jiangzhou Medical Device Co., Ltd., representing 13.73%, 9.14% and 9.05% of our total purchase respectively. For the year ended Decemb… |
| MEIHUA-FUTURE-MANUFACTURING-LIMITED |
MEIHUA-FUTURE-MANUFACTURING-LIMITED |
62%
|
uses on the manufacturing, sales and distributions of non-bottled products, such as brushes, ID bracelets for domestic sales. ● Jiangsu Yada Technology Group Co., Ltd., or Jiangsu Yada: a subsidiary … |
| OVERSEAS-PUBLICLY-LISTED-COMPANY |
OVERSEAS-PUBLICLY-LISTED-COMPANY |
62%
|
lt or impossible. 23 We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability… |
| SHANGHAI-BLUEHILL-ADVISORY-CO-LTD |
SHANGHAI-BLUEHILL-ADVISORY-CO-LTD |
62%
|
lt or impossible. 23 We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability… |
| TIANYI-MEDICAL-DEVICE-CO-LTD |
TIANYI-MEDICAL-DEVICE-CO-LTD |
62%
|
hou Tianyi Medical Device Co., Ltd., Yangzhou Xiaguang Medical Device Co., Ltd., and Yangzhou Jiangzhou Medical Device Co., Ltd., representing 12.14%, 9.93% and 8.67% of our total purchase respective… |
| U-S-MEIHUA-INTERNATIONAL-MEDICAL-TECHNOLOGIES-CO |
U-S-MEIHUA-INTERNATIONAL-MEDICAL-TECHNOLOGIES-CO |
62%
|
uses on the manufacturing, sales and distributions of non-bottled products, such as brushes, ID bracelets for domestic sales. ● Jiangsu Yada Technology Group Co., Ltd., or Jiangsu Yada: a subsidiary … |
| WORKING-GROUP |
WORKING-GROUP |
62%
|
lt or impossible. 23 We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability… |
| YANGZHOU-HUADA-MEDICAL-DEVICE-CO-LTD |
YANGZHOU-HUADA-MEDICAL-DEVICE-CO-LTD |
62%
|
t of Meihua’s operating subsidiaries in China: ● Yangzhou Huada Medical Device Co., Ltd., or Yangzhou Huada: a subsidiary wholly owned by Kang Fu International Medical and established in Yangzhou, Ji… |
| YANGZHOU-JIANGZHOU-MEDICAL-DEVICE-CO-LTD |
YANGZHOU-JIANGZHOU-MEDICAL-DEVICE-CO-LTD |
62%
|
, Ltd., Yangzhou Xiaguang Medical Device Co., Ltd., and Yangzhou Jiangzhou Medical Device Co., Ltd., representing 13.73%, 9.14% and 9.05% of our total purchase respectively. For the year ended Decemb… |
| YONGJUN-LIU-YIN-LIU-ACE-CAPITAL-LIMITED |
YONGJUN-LIU-YIN-LIU-ACE-CAPITAL-LIMITED |
62%
|
lt or impossible. 23 We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability… |
